- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Privia Health CEO Sells Over $479K in Shares
Parth Mehrotra, the CEO of Privia Health Group, has sold a significant number of shares in recent days.
Mar. 12, 2026 at 10:41pm
Got story updates? Submit your updates here. ›
Parth Mehrotra, the CEO of Privia Health Group (NASDAQ:PRVA), has sold a total of 84,536 shares of the company's stock over the past week. The shares were sold at an average price of $22.91, resulting in a total transaction value of over $1.9 million. Following the sales, Mehrotra still owns 322,698 shares in the company, valued at approximately $7.3 million.
Why it matters
Insider selling can sometimes be a signal of management's confidence in the company's future prospects. However, it's important to note that insiders may sell shares for a variety of reasons, such as personal financial planning, and the sales do not necessarily reflect the company's outlook.
The details
The share sales were made in three separate transactions on March 6th, March 9th, and March 10th. Mehrotra sold a total of 21,440 shares on March 6th, 41,999 shares on March 9th, and 21,097 shares on March 10th. All of the shares were sold at an average price of around $22.91.
- On March 6th, Mehrotra sold 21,440 shares.
- On March 9th, Mehrotra sold 41,999 shares.
- On March 10th, Mehrotra sold 21,097 shares.
The players
Parth Mehrotra
The CEO of Privia Health Group, Inc.
Privia Health Group, Inc.
A physician enablement company that partners with independent physicians, medical groups, and health systems to transform the delivery of patient care.
The takeaway
While the CEO's share sales are notable, it's important for investors to consider the broader context and not overreact to insider transactions. Privia Health Group's business model and long-term prospects will likely be more important factors in determining the company's future performance.
